Table 3.

Odds ratios (ORs) and standard errors (Std Errors) from fully adjusted logistic regression models for hormone-related drugs in women and men. Here p-values <0.05 were considered statistically significant and are in shaded cells.

Drug	1-year lag analysis					3-year lag analysis
	% exposed					% exposed
	Cases	Controls	OR	Std Error	p-value	Cases	Controls	OR	Std Error	p-value
Women
Estrogens, conjugated	8.09	5.94	1.16	0.05	0.007	6.17	5.10	0.99	0.07	0.90
Estradiol	5.53	4.32	1.01	0.065	0.851	4.06	3.24	0.94	0.09	0.49
Estradiol/levonorgestrel	–	–	0.42	1.03	0.407	0.69	0.14	0.58	1.05	0.60
Estradiol/norethindrone	–	–	0.68	0.37	0.293	–	–	0.83	0.43	0.66
Estrogen,con/m-progest	0.67	0.67	0.85	0.18	0.355	0.52	0.55	0.77	0.26	0.23
Raloxifene	3.60	3.42	0.94	0.08	0.447	3.16	2.96	0.91	0.10	0.33
Tamoxifen	0.56	0.75	0.62	0.19	0.011	0.45	0.59	0.61	0.25	0.04
Testosterone	–	–	3.93	0.45	0.002	–	–	4.92	0.54	0.003
Men	–	–	–	–	–	–	–	–	–	–
Testosterone	2.22	1.41	1.27	0.10	0.027	1.29	0.90	1.12	0.15	0.47
Tamoxifen	–	–	1.65	0.65	0.442	–	–	–	–	–
Estrogens, conjugated	–	–	1.48	0.78	0.616	–	–	–	–	–